{'fraction_non_alphanumeric': 0.011730205278592375, 'fraction_numerical': 0.001466275659824047, 'mean_word_length': 5.443396226415095, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Therapeutic effect of lipoprostaglandin E1 on livedoid vasculitis associated with essential cryoglobulinaemia

with psoriasis can be due to causes other than PsA, such as OA or gout. With lack of formal diagnostic criteria, a more streamlined approach is needed to detect PsA early and to discriminate from other causes of musculoskeletal pain. Until such criteria are developed, a close working relationship between the rheumatologist and the dermatologist seems vital to providing optimal care for patients with psoriasis and PsA. Further research is needed to help identify which patients with PsA will progress to erosive, destructive joint disease and require systemic therapy.